Accueil / Tag Archives: Product/Service

Tag Archives: Product/Service

Masimo Anuncia la Marca CE de RPVi™ No Invasivo, un Índice de Variabilidad Pletismográfica de Longitud de Onda Múltiples rainbow®

Friday, July 21st 2017 at 3:54am UTC NEUCHATEL, Suiza–(BUSINESS WIRE)– Masimo (NASDQ: MASI) anunció hoy la marca CE de RPVi™, una medición continua y no invasiva de los cambios dinámicos en el índice de perfusión (Perfusion Index, PI) que se produce durante uno o más ciclos respiratorios. El RPVi está …

Plus »

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy

Friday, July 21st 2017 at 11:26am UTC Positive opinion based on the results of two randomized Phase 3 trials, TELESTAR and TELECAST PARIS–(BUSINESS WIRE)– Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines …

Plus »

Sunovion’s Latuda® (lurasidone HCI) Receives Health Canada Approval to Treat Adolescents with Schizophrenia

Friday, July 21st 2017 at 3:30pm UTC – Health Canada has also accepted for review a Supplemental New Drug Submission (SNDS) for LATUDA for the treatment of bipolar depression in pediatric patients – MARLBOROUGH, Mass.–(BUSINESS WIRE)– Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Health Canada approved the Supplemental New Drug …

Plus »

Reviva Pharmaceuticals Announces Addition of a New Member to its Board of Directors

Friday, July 21st 2017 at 9:15pm UTC SANTA CLARA, Calif.–(BUSINESS WIRE)– Reviva Pharmaceuticals, Inc. (Reviva), a privately held, clinical stage pharmaceutical company developing next generation therapies for CNS, cardiopulmonary, and metabolic diseases, today announced that biotech industry veteran Bradley Thompson has joined its Board of Directors. “We are extremely pleased …

Plus »

Ipsen reçoit un avis favorable du CHMP à l’octroi d’une AMM pour Xermelo® (télotristat éthyl), dans le traitement de la diarrhée associée au syndrome carcinoïde chez les patients insuffisamment contrôlés par un analogue de la somatostatine

Friday, July 21st 2017 at 11:26am UTC Avis favorable fondé sur les résultats de deux études randomisées de phase 3, TELESTAR et TELECAST PARIS–(BUSINESS WIRE)– Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) a annoncé aujourd’hui que le Comité des médicaments à usage humain (CHMP : Committee for Medicinal Products for …

Plus »

Masimo annonce le marquage CE du RPVi™ non invasif, un indice de variabilité de la pléth à plusieurs longueurs d’ondes rainbow®

Friday, July 21st 2017 at 12:14pm UTC NEUCHÂTEL, Suisse–(BUSINESS WIRE)– Masimo (NASDAQ : MASI) a annoncé aujourd’hui le marquage CE de RPVi™, une mesure non invasive continue des changements dynamiques de l’indice de perfusion (iP) qui se produisent dans un ou plusieurs cycles respiratoires. RPVI est conçu pour indiquer les changements …

Plus »

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV

Friday, July 21st 2017 at 12:09pm UTC Proven efficacy and durability of darunavir combined with the improved renal laboratory and bone mineral density profile of emtricitabine/tenofovir alafenamide as compared to emtricitabine/tenofovir disoproxil fumarate into one single tablet BEERSE, Belgium–(BUSINESS WIRE)– Janssen-Cilag International NV (Janssen) today announced that the Committee for …

Plus »

Syros Publishes Foundational Data Supporting Ongoing Phase 2 Clinical Trial of SY-1425 for Genomically Defined AML and MDS Patients

Friday, July 21st 2017 at 12:01pm UTC Data Underscore Promise of Syros’ Gene Control Platform to Provide New Approach for Stratifying Patients with Potential to Lead to More Precise Diagnosis and Treatment CAMBRIDGE, Mass.–(BUSINESS WIRE)– Syros Pharmaceuticals (NASDAQ: SYRS) today announced that data providing the foundation of its clinical development …

Plus »

Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease

Thursday, July 20th 2017 at 12:00pm UTC – IW-3718 1500 mg demonstrated a significant reduction in heartburn severity in patients with uncontrolled GERD – – Greater than 50% of patients treated with IW-3718 1500 mg achieved a clinically meaningful reduction in heartburn severity – – IW-3718 1500 mg also showed …

Plus »

Netsmart Continues Post-Acute Expansion with DeVero Acquisition

Wednesday, July 19th 2017 at 12:30pm UTC OVERLAND PARK, Kan.–(BUSINESS WIRE)– Netsmart announced it has acquired DeVero, a healthcare technology company that specializes in home healthcare and hospice. Netsmart is an innovative healthcare technology provider that provides electronic health records (EHRs), health information exchange, data analytics, mobile clinical and consumer …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...